Yebin Im
3 Papers
Yebin Im is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
A Comprehensive Overview of RNA Deconvolution Methods and Their Application
Yebin Im,Yongsoo Kim +1 more
TL;DR: A comprehensive review of 20 statistical deconvolution methods for tumor microenvironments can be found in this paper , with three primary criteria: characteristics of methodology, use of prior knowledge of cell types and outcome of the methods.
42
Latrophilin-2 is a novel receptor of LRG1 that rescues vascular and neurological abnormalities and restores diabetic erectile function
Guo Nan Yin,Do-Kyun Kim,Ji In Kang,Yebin Im,Dong-Sun Lee,Ah Reum Han,Jiyeon Ock,Min Ji Choi,Mi-Hye Kwon,Anita Limanjaya,Saet-Byel Jung,Jimin Yang,Kwang Wook Min,Jeong Sik Yun,Yongjun Koh,Jong-Eun Park,Dae-Ryong Hwang,Jun-Kyu Suh,Ji-Kan Ryu,Ho Min Kim +19 more
TL;DR: In this paper , the authors found that the adhesion GPCR latrophilin-2 (LPHN2) is a TGF-βindependent receptor of LRG1.
Nicotinamide (niacin) supplement increases lipid metabolism and ROS‐induced energy disruption in triple‐negative breast cancer: potential for drug repositioning as an anti‐tumor agent
Minsun Jung,Kyungwon Lee,Yebin Im,Seung Hyeok Seok,Hye Ryung Chung,Da Young Kim,Dohyun Han,Cheng Hyun Lee,Eun Hye Hwang,Soo Young Park,Jiwon Koh,Bohyun Kim,Ilias P. Nikas,Hyebin Lee,Dae-Ryong Hwang,Han Suk Ryu +15 more
TL;DR: It is shown that NAM treatment leads to cancer cell death in TNBC via mitochondrial dysfunction and activation of ROS by bifurcating metabolic pathways (RET and lipid metabolism); this provides insights into the repositioning of NAM supplement as a next‐generation anti‐metabolic agent for TNBC treatment.
24